Stay updated on Roxadustat in End-Stage Renal Disease Clinical Trial
Sign up to get notified when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.

Latest updates to the Roxadustat in End-Stage Renal Disease Clinical Trial page
- Check6 days agoChange DetectedA banner announces an NIH website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the full study record with a basic error view. The additions reflect the error page elements (403, HTML header, Home, Revision: v3.7.0), and the detailed study content has been removed.SummaryDifference21%

- Check61 days agoChange DetectedThe study page's revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s documentation/versioning. It does not alter the study data or displayed content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision updated to v3.6.5 (replacing v3.6.4), indicating a small metadata update rather than substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Roxadustat in End-Stage Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.